Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617

Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617

<b>Background</b>: We hypothesized that the Effective radiation Dose to the Immune Cells (EDIC) in circulating blood is a significant factor for the treatment outcome in patients with locally advanced non-small-cell lung cancer (NSCLC). <b>Methods</b>: This is a secondary stu...

Full description

Bibliographic Details
Main Authors: Jian-Yue Jin, Chen Hu, Ying Xiao, Hong Zhang, Rebecca Paulus, Susannah G. Ellsworth, Steven E. Schild, Jeffrey A. Bogart, Michael Chris Dobelbower, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Cliff Robinson, Joel S. Greenberger, Christopher Koprowski, Mitchell Machtay, Walter Curran, Hak Choy, Jeffrey D. Bradley, Feng-Ming (Spring) Kong
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
non-small-cell lung cancer
radiotherapy
survival
radiation-induced immune toxicity
Online Access:https://www.mdpi.com/2072-6694/13/24/6193

Internet

https://www.mdpi.com/2072-6694/13/24/6193

Similar Items